Abstract
More than a quarter of a million IsraeLi citizens live today with the diagnosis of cancer being a part of their past medical history. The volume of this population is going to enlarge in coming years. These patients tend to suffer from several unique medical and psychosocial difficulties due to their original malignant disease and its risk factors, as a consequence of the antineoplastic treatments they had received, and as a result of exceptional presentation of concomitant non-neoplastic diseases. In this review, we describe the current dilemmas that exist in the medical community concerning the appropriate setting and extent of care that are needed in order to deliver suitable care for this growing population, and emphasize the need for further research and the development of clinical excellence in the treatment of this population.
Original language | English |
---|---|
Pages (from-to) | 46-49, 60 |
Journal | Harefuah |
Volume | 151 |
Issue number | 1 |
State | Published - Jan 2012 |